Clinical trial
A Pilot Feasibility And Safety Multicenter Trial Of Administering Weight Adjusted Fixed Dose Of Low Molecular Weight Heparin (Enoxaparin) To Neonates and Children With Thrombosis (FiXET)
NCT02486666 is registered in ClinicalTrials.gov with Hamilton Health Sciences Corporation as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Pilot Feasibility And Safety Multicenter Trial Of Administering Weight Adjusted Fixed Dose Of Low Molecular Weight Heparin (Enoxaparin) To Neonates and Children With Thrombosis (FiXET)
- Lead sponsor
- Hamilton Health Sciences Corporation
- Phase
- Phase 3
- Overall status
- Unknown status
- Start date
- March 31, 2016
- Completion date
- December 31, 2022
- Enrollment
- 20 (estimated)
- Sites
- 4
Conditions
As the registry lists them; a condition with its own page is linked.